CHRISTINE FEATHERS: Open Payments
NPI 1285635243 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 16 payments from 8 companies in 2025. Trend: 2023 $372 · 2024 $295 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $85 |
| Novo Nordisk Inc | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| ABBVIE INC. | 1 | $21 |
| Seqirus USA Inc | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: JARDIANCE, Ozempic, SHINGRIX, AIRSUPRA, KISUNLA, UBRELVY, TRELEGY ELLIPTA, BREZTRI.
Industry payments across MD — which companies pay providers there.
